Mode
Text Size
Log in / Sign up

Case-control study links splenomegaly to elevated metabolic and inflammatory markers in chronic schizophreniaWhy do some people with schizophrenia develop an enlarged spleen?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider monitoring metabolic and inflammatory markers in chronic schizophrenia patients with splenomegaly, recognizing this is an association.

A case-control study analyzed 426 patients with chronic schizophrenia (165 with splenomegaly, 261 without) to identify risk factors for splenomegaly and explore associations among metabolic-immunoinflammatory pathways, psychiatric symptoms, and splenomegaly. The primary outcome was identifying risk factors, with secondary outcomes examining these pathway associations. The study setting and specific intervention or exposure were not reported, with the comparator being the non-splenomegaly group.

The main finding was that the splenomegaly group had significantly higher levels of lipoprotein(a), cholesterol, triglycerides, HbA1c, CRP, IL-6, and β2-microglobulin compared to the group without splenomegaly. The result was reported as statistically significant (p < 0.05 implied), but exact effect sizes, absolute numbers, and confidence intervals were not provided. The direction of association was higher for all measured markers in the splenomegaly group.

Safety and tolerability data were not reported. Key limitations include the observational case-control design, which precludes causal inference, and the lack of reported effect sizes and absolute numbers. Funding sources and conflicts of interest were also not reported. The practice relevance is cautiously framed as potentially helping to optimize somatic monitoring strategies by highlighting associated metabolic and inflammatory markers in patients with chronic schizophrenia and splenomegaly.

Living with schizophrenia means managing both mental and physical health. A new study looked at a specific physical issue—an enlarged spleen, or splenomegaly—in 426 people with chronic schizophrenia. The researchers found that the 165 people with an enlarged spleen had significantly higher levels of several markers in their blood compared to those without. These markers included cholesterol, triglycerides (blood fats), a long-term blood sugar measure (HbA1c), and several proteins linked to inflammation and immune system activity.

This finding matters because it connects a physical symptom to a broader pattern of metabolic and immune system changes. It suggests that when doctors see an enlarged spleen in someone with schizophrenia, it could be a red flag pointing to these other health concerns. The study's goal is to help optimize how doctors monitor and address the whole-body health of their patients.

However, this was an observational case-control study. That means it can only show that these things are associated—they tend to appear together. It cannot prove that high cholesterol or inflammation causes the spleen to enlarge, or vice versa. The researchers also did not report how much higher the levels were or the exact numbers of people affected, so we don't know the strength of these links. The work highlights an important connection to watch, but more research is needed to understand what it truly means for care.

What this means for you:
An enlarged spleen in schizophrenia is linked to higher blood fats, sugar, and inflammation.

Study Details

Study typeCase control
EvidenceLevel 4
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis study aimed to identify risk factors for splenomegaly in chronic schizophrenia patients and clarify associations among metabolic−immunoinflammatory pathways, psychiatric symptoms and splenomegaly. The findings will help optimize somatic monitoring and intervention strategies.MethodsA case−control design was used. A total of 426 patients were assigned to splenomegaly (n= 165) and non−splenomegaly (n= 261) groups according to abdominal ultrasound. Demographic data, clinical information, and antipsychotic use were collected. Mental symptoms were assessed by the Positive and Negative Syndrome Scale. Hematological indicators were detected, and abdominal ultrasound was performed to evaluate spleen morphology and fatty liver occurrence. SPSS 24.0 was used for statistical analysis, including univariate analysis and binary logistic regression to screen influencing factors of splenomegaly.ResultsThe splenomegaly group had significantly higher levels of lipoprotein(a), cholesterol, triglycerides, HbA1c, CRP, IL-6 and β2-microglobulin than the non-splenomegaly group (all p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.